Explore more publications!

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on March 25, 2026

As The Idaho Drug Problem Reaches Crisis Levels, Icarus Wellness and Recovery Offers Critical Solutions
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
XORTX Announces Share Consolidation
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
ATI Advisory Releases New Analysis of MSSP ACO Episodes, Highlighting Concentrated Financial Exposure and Opportunity Under LEAD
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
BeyondSpring Files 2025 Annual Report on Form 10-K
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
Exicure, Inc. Reports Full Year 2025 Financial Results
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
Lifeward Successfully Closes on Strategic Partnership with Oramed
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions